AptarGroup Posts Strong Q2 Growth, Net Sales Up 3.6%

Ticker: ATR · Form: 10-Q · Filed: Aug 1, 2025 · CIK: 896622

Sentiment: bullish

Topics: Packaging, Drug Delivery, Q2 Earnings, Revenue Growth, Net Income, Industrial Applications, Plastics Products

Related Tickers: ATR, BBY, SLGN

TL;DR

AptarGroup's Q2 numbers are solid, showing consistent growth and making it a reliable play in a volatile market.

AI Summary

APTARGROUP, INC. reported net sales of $870.0 million for the second quarter ended June 30, 2025, an increase from $840.0 million in the prior-year quarter. The company's net income for the second quarter of 2025 was $75.0 million, up from $68.0 million in the second quarter of 2024. For the six months ended June 30, 2025, net sales reached $1,700.0 million, compared to $1,650.0 million for the same period in 2024. Net income for the first half of 2025 was $140.0 million, an improvement from $130.0 million in the first half of 2024. The company's strategic outlook emphasizes continued growth in its Pharma and Beauty + Home segments, driven by innovation and market expansion. Key risks include fluctuating raw material costs and global supply chain disruptions, which could impact profitability. APTARGROUP is actively managing these risks through diversified sourcing and operational efficiencies.

Why It Matters

APTARGROUP's consistent revenue and net income growth, with Q2 net sales up 3.6% to $870.0 million, signals robust demand for its dispensing and drug delivery solutions, which is positive for investors. This performance suggests the company is effectively navigating competitive pressures in the packaging and drug delivery sectors, potentially strengthening its market position against rivals like Berry Global and Silgan Holdings. Employees benefit from a stable and growing company, while customers can expect continued innovation in product offerings. The broader market sees a resilient player in essential industries, contributing to overall economic stability.

Risk Assessment

Risk Level: medium — The risk level is medium due to potential exposure to fluctuating raw material costs and global supply chain disruptions, as mentioned in the strategic outlook. While the company reported strong financial performance with net sales up 3.6% to $870.0 million in Q2 2025, these external factors could impact future profitability and operational efficiency, creating uncertainty despite current growth.

Analyst Insight

Investors should consider holding ATR, given its consistent revenue growth of 3.6% in Q2 2025 and a 7.0% increase in net income to $75.0 million. The company's ability to grow amidst market challenges suggests resilience, making it a stable long-term investment.

Financial Highlights

debt To Equity
N/A
revenue
$1,700.0M
operating Margin
N/A
total Assets
N/A
total Debt
N/A
net Income
$140.0M
eps
N/A
gross Margin
N/A
cash Position
N/A
revenue Growth
+3.6%

Revenue Breakdown

SegmentRevenueGrowth
PharmaN/AN/A
Beauty + HomeN/AN/A

Key Numbers

Key Players & Entities

FAQ

What were APTARGROUP, INC.'s net sales for the second quarter of 2025?

APTARGROUP, INC. reported net sales of $870.0 million for the second quarter ended June 30, 2025, an increase from $840.0 million in the prior-year quarter.

How did APTARGROUP, INC.'s net income change in Q2 2025 compared to Q2 2024?

The company's net income for the second quarter of 2025 was $75.0 million, up from $68.0 million in the second quarter of 2024, representing a 10.3% increase.

What is APTARGROUP, INC.'s strategic outlook for its business segments?

APTARGROUP, INC.'s strategic outlook emphasizes continued growth in its Pharma and Beauty + Home segments, driven by innovation and market expansion.

What are the key risks identified by APTARGROUP, INC. in its 10-Q filing?

Key risks identified include fluctuating raw material costs and global supply chain disruptions, which could impact profitability and operational efficiency.

What were APTARGROUP, INC.'s net sales for the first six months of 2025?

For the six months ended June 30, 2025, net sales reached $1,700.0 million, compared to $1,650.0 million for the same period in 2024.

How does APTARGROUP, INC.'s performance impact investors?

APTARGROUP, INC.'s consistent revenue and net income growth, with Q2 net sales up 3.6% to $870.0 million, signals robust demand for its solutions, which is positive for investors.

What is APTARGROUP, INC. doing to mitigate identified risks?

APTARGROUP, INC. is actively managing risks such as fluctuating raw material costs and supply chain disruptions through diversified sourcing and operational efficiencies.

What industry does APTARGROUP, INC. primarily operate in?

APTARGROUP, INC. primarily operates in the plastics products industry, specifically focusing on dispensing and drug delivery solutions.

What was the net income for APTARGROUP, INC. for the first half of 2025?

Net income for the first half of 2025 was $140.0 million, an improvement from $130.0 million in the first half of 2024.

When was APTARGROUP, INC.'s 10-Q filing submitted?

APTARGROUP, INC.'s 10-Q filing was submitted on August 1, 2025, for the period ending June 30, 2025.

Risk Factors

Industry Context

AptarGroup operates in the plastics products manufacturing sector, serving diverse markets including Pharma and Beauty + Home. The industry is characterized by innovation in dispensing solutions and packaging, with a growing emphasis on sustainability. Competitive pressures often stem from material costs and the ability to deliver specialized, high-quality products.

Regulatory Implications

While no specific new regulatory changes are detailed in the summary, companies like AptarGroup are subject to general manufacturing and environmental regulations. Compliance with product safety standards, particularly in the Pharma and Beauty segments, is critical.

What Investors Should Do

  1. Monitor raw material cost trends and AptarGroup's hedging/sourcing strategies.
  2. Track growth and innovation in the Pharma and Beauty + Home segments.
  3. Assess the impact of global supply chain dynamics on AptarGroup's operations.

Key Dates

Glossary

10-Q
A quarterly report required by the U.S. Securities and Exchange Commission (SEC) that provides a comprehensive update on a company's financial performance. (This document is the 10-Q filing for AptarGroup, Inc., detailing its financial status for the period ending June 30, 2025.)
Net Sales
The total revenue generated from sales after deducting returns, allowances, and discounts. (Key top-line metric indicating the company's revenue performance, which increased to $870.0 million in Q2 2025 and $1,700.0 million for H1 2025.)
Net Income
The profit remaining after all expenses, taxes, and interest have been deducted from revenue. (Crucial bottom-line metric showing profitability. AptarGroup reported $75.0 million for Q2 2025 and $140.0 million for H1 2025, both increases from the prior year.)

Year-Over-Year Comparison

Compared to the previous year's filing, AptarGroup demonstrates positive momentum with a 3.6% increase in Q2 net sales and a 10.3% rise in Q2 net income. The first half of 2025 also shows sustained growth in both sales and net income. New risks highlighted include the potential impact of fluctuating raw material costs and global supply chain disruptions, which the company is actively managing.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on August 1, 2025 regarding APTARGROUP, INC. (ATR).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing